HIT Consultant August 19, 2025
Thomas Kluz, Managing Director at Niterra Ventures

The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.

Drug development has long been marked by high costs, inefficiency, and human trial-and-error. Indeed, the cost of developing a single therapeutic exceeds $2.6 billion according to the Tufts Center for the Study of Drug Development. Much of this expense can be attributed to the clinical trial process.

Clinical trials are a true bottleneck in pharmaceutical innovation. Not only are they slow and expensive, but they often fail to produce data that is broadly applicable. Securing patients is perhaps one of the greatest challenges in conducting a clinical trial. Even with modern recruitment platforms and global trial networks,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Clinical Trials, Pharma, Pharma / Biotech, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article